Assessing Ketone levels achieved after varying doses of Medium Chain Triglyceride (MCT) oil
Assessing Ketone levels achieved after varying doses of Medium Chain Triglyceride (MCT) oil in three study populations: \<65 year healthy, 65 and older healthy, and Alzheimer's disease. Each subject attends for 4 study days, receiving incrementally larger MCT doses at each visit for 0g, to 14g, to 28g to 42g.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
25
Bulletproof Braine Octane MCT oil
University of Alberta
Edmonton, Alberta, Canada
Maximum plasma concentration (Cmax)
Calculation of Cmax to varying doses in each subject and in different study arms.
Time frame: 3 months
Time to maximum plasma concentration (tmax)
Calculation of tmax to varying doses in each subject and in different study arms.
Time frame: 3 months
Area under the curve (AUC)
Calculation of AUC to varying doses in each subject and in different study arms.
Time frame: 3 months
weight
measured in kg
Time frame: 3months
height
measured in cm
Time frame: 3 months
BMI
Calculated BMI (ht/m2)
Time frame: 3months
Body fat
% measured by bioimpedence scale
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.